Prostate Free Means Brain Free - Prostate Drugs Could Damage Your Brain - http://clapway.com/2015/12/09/prostate-free-means-brain-free-prostate-drugs-could-damage-your-brain

For men looking to avoid prostate cancer, another risk might be involved. An analysis of electronic medical records was recently published and it explains a problem for men who take drugs to prevent prostate cancer. That new problem is the risk of Alzheimer’s disease.

PROSTATE DRUGS COULD GIVE YOU ALZHEIMER’S

The study that was recorded stated that the men who take prostate drugs will double their chance of damaging their brain via Alzheimer’s. The study explained that the drugs that men take to prevent this cancer reduce their hormones and testosterone levels. The problem is that they say that doing this can link you to a higher risk of brain loss. They also stated that the men who take these drugs, survival rate does not increase. So, is there a point to take these drugs if they do not improve your survival percentage and give you a higher risk of Alzheimer’s?

PROSTATE DRUG USERS

Even though there is this huge risk, the study shown shows that many men are still active with prostate drugs. The study showed that over half a million men in the Unites States are still taking these drugs. Some experts involved in the study mention how this might be because some men know they will not be able to get surgery for it. This leads them to take it to try and do all they can to prevent this cancer. However, Alzheimer’s is no joke and is a disease you do not want to higher your risk for.

WHAT IS WORSE THAN, PROSTATE CANCER OR ALZHEIMER’S?

Both of these are awful epidemics. Maybe the only plus to prostate cancer is the fact that it can be cured, but Alzheimer’s, on the other hand, can not. As of now, there are no cures to it. No matter what, though, both of these are terrible and would be best to never experience.

Prostate Free Means Brain Free - Prostate Drugs Could Damage Your Brain

Prostate Cancer-Less Likely to Be Treated, and Just as Deadly - http://clapway.com/2015/07/08/prostate-cancer-less-likely-to-be-treated-and-just-as-deadly453/

Turns out that prostate cancer is deadlier for your than you may realize.

Research has indicated that prostate cancer is more likely to be observed rather than treated directly. These observations come from the University of California, San Francisco, where the concerns of overtreatment are being addressed.

The research conducted at UCSF found that men with low-risk prostate cancer are undergoing active surveillance, rather than aggressive treatment, in hopes of curing the illness. This process, called “watchful waiting”, includes with the hopes of avoiding more invasive options such as surgery or radiation.

Some believe that watchful waiting can be more productive in the journey to a cure, as prostate cancer develops slower in comparison to other forms of cancer.

Research data came from study of over 10,000 us patients

The data comes to us from the study of more than 10,000 patients at clinics across the US, from 1990 to 2013. When it came to men ages 75 and older, there was a surveillance rate ranged from 54 percent from 1990-1994; 22 percent from 2000-2004, and 76 percent from 2010-2013. It was revealed through the study that older men exhibited longer periods of watchful waiting.

is watchful waiting really the best option?

While watchful waiting is being considered more as a viable treatment option, there is still division from within the medical community on whether it is the best option for patients with prostate cancer. Cancer.org defines watchful waiting and compares it to active surveillance, suggesting that these two options are different despite their frequent interchangeability. Watchful waiting is described as “a less intensive type of follow-up that may mean fewer tests and relying more on changes in a man’s symptoms to decide if treatment is needed”, while active surveillance involves “monitoring the cancer closely with prostate-specific antigen (PSA) blood tests, digital rectal exams (DREs), and ultrasounds at regular intervals to see if the cancer is growing”. Disagreement of definition goes as far as between doctors, as each may have a different perception of the effectiveness and limitations of each form of treatment.

While it is unclear whether there shall be a truly universal definition for watchful waiting, active surveillance, or anything in between, it does seem clear that treatment options for low-risk prostate cancer patients may not stay limited to invasive treatments for long.

---

 

Want to keep your notes clear, organized, and protected when you’re out in the field? Check out Moleskine’s Voyageur Traveller’s notebook.

Prostate Cancer-Less Likely to Be Treated, and Just as Deadly